NCT05588609 2025-09-18Study Evaluating Zenocutuzumab in Patients With or Without Molecularly Defined CancersMerus B.V.Phase 2 Terminated13 enrolled
NCT03685591 2024-06-26PF-06952229 Treatment in Adult Patients With Advanced Solid TumorsPfizerPhase 1 Terminated49 enrolled 33 charts